Abstract
Response to Comment on: "Efficacy and Safety of Saroglitazar in Patients with Cardiometabolic Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials".
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have